Sunday, August 13, 2017 9:32:32 AM
What else company can do in the meantime to increase the value of co for BO
1. File CE mark application - not sure where this stands and when it will happen - in 2017?
Even if they file the approval cycle is 6-9 months
2. Start a new trial in US for internal application - this is a biggie and will add huge value - the actual trial time will be same - less than 1 hour per patient and then 1 month follow up
Based on Europe trial - they can easily do it - but do they have resources for this?
As this will be short trial - starting it will push high - but company has not indicated as 2017 milestone.
3. Announce partnership so they can start multiple trials - unlikely as they are focused on BO
Hopefully they can surprise us by doing one of the 3 or somethig else such as submitting IND for new indication.
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM